Skip to content

To explore the mechanism of Guishen Huoxue Decoction in treating intrauterine adhesion based on network pharmacology

To explore the mechanism of Guishen Huoxue Decoction in treating intrauterine adhesion based on network pharmacology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063045
Enrollment
Unknown
Registered
2022-08-29
Start date
2022-08-30
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrauterine adhesion

Interventions

Experimental group:Guishen Huoxue Decoction

Sponsors

Shenzhen Bao'an Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women of childbearing age (18-40 years old) who meet the diagnostic criteria of intrauterine adhesions in Western medicine and have childbearing requirements; 2. In line with TCM syndrome differentiation, it belongs to the type of kidney deficiency and blood stasis; 3. Those diagnosed with intrauterine adhesions by hysteroscopy; 4. No similar traditional Chinese medicine or hormone therapy within 1 month before inclusion.

Exclusion criteria

Exclusion criteria: 1. Cervical adhesions; 2. Combined with serious diseases such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic system; 3. Menstrual disorders caused by abnormal hypothalamus-pituitary-ovary axis; 4. Other endocrine diseases, such as congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, diabetes, thyroid disease, etc.; 5. Congenital defects and deformities of the reproductive system; 6. Reproductive system tuberculosis; 7. Those who do not meet the inclusion criteria, or do not take medication on time, cannot judge the curative effect or have incomplete data, etc., which affect our judgment of curative effect and safety; those who are allergic to this drug.

Design outcomes

Primary

MeasureTime frame
Menstrual status;syndrome of traditional Chinese medicine;

Secondary

MeasureTime frame
Intrauterine adhesions score;endometrial thickness;

Countries

China

Contacts

Public ContactWenyan Zhang

Shenzhen Bao'an Chinese Medicine Hospital

21581968@qq.com+86 18927418013

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026